购物车
- 全部删除
- 您的购物车当前为空
BVFP是一种PGRN-SORT1抑制剂/SORT1拮抗剂,能够与PGRN588–593关键残基结合。PGRN是一种多功能分泌性糖蛋白,SORT1是PGRN的神经元受体。BVFP能够阻断PGRN-SORT1的结合,恢复细胞外PGRN水平,抑制SORT1介导的rPGRN内吞作用,具有治疗额颞叶痴呆(FTLD-TDP)的潜力。
为众多的药物研发团队赋能,
让新药发现更简单!
BVFP是一种PGRN-SORT1抑制剂/SORT1拮抗剂,能够与PGRN588–593关键残基结合。PGRN是一种多功能分泌性糖蛋白,SORT1是PGRN的神经元受体。BVFP能够阻断PGRN-SORT1的结合,恢复细胞外PGRN水平,抑制SORT1介导的rPGRN内吞作用,具有治疗额颞叶痴呆(FTLD-TDP)的潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,630 | 现货 | |
5 mg | ¥ 4,220 | 现货 | |
10 mg | ¥ 5,990 | 现货 | |
25 mg | ¥ 8,890 | 现货 | |
50 mg | ¥ 11,900 | 现货 | |
100 mg | ¥ 15,900 | 现货 | |
200 mg | ¥ 21,800 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 3,180 | 现货 |
产品描述 | BVFP is a PGRN-SORT1 inhibitor/SORT1 antagonist that binds to key residues 588-593 of PGRN, a multifunctional secreted glycoprotein, and SORT1, a neuronal receptor for PGRN.BVFP is able to block PGRN-SORT1 binding, restore extracellular levels of PGRN , inhibits SORT1-mediated rPGRN endocytosis, and has therapeutic potential for frontotemporal lobe dementia (FTLD-TDP). |
分子量 | 345.12 |
分子式 | C13H8BrF3N2O |
CAS No. | 357158-20-4 |
Smiles | O=C1N=C(C=CC=2C=CC=C(Br)C2)C=C(N1)C(F)(F)F |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 40.00 mg/mL (115.90 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
评论内容